Form 4: BullFrog AI Director Granted 15,000 Stock Options

BullFrog AI Holdings, Inc. Director Jason David Hanson was granted 15,000 stock options with an exercise price of $1.43 under the company's 2022 Equity Compensation Plan.

Summary

• Jason David Hanson, a Director of BullFrog AI Holdings, Inc. (BFRG), acquired 15,000 stock options.
• The options were granted on September 25, 2025, with an exercise price of $1.43 per share.
• These options were issued under the company's 2022 Equity Compensation Plan, as amended.
• The options vest on the earlier of September 25, 2026, or the date of the company's annual meeting for fiscal year 2026.
• Forfeiture restrictions will accelerate upon a change in control of the company or a significant financing event.
• The stock options are set to expire on September 25, 2035.
• The options were granted at a price of $0.00, based on the market price on the grant date.

Sentiment

Score: 6

Explanation: The grant of stock options to a director is a routine event that aligns management interests with shareholders, which is generally positive. However, it does not represent a significant new development or financial performance indicator.

Positives

• The grant of stock options aligns the interests of Director Jason David Hanson with those of shareholders, incentivizing long-term company performance.
• Equity compensation is a standard practice for attracting and retaining qualified directors and executives.

Risks

• Potential future dilution for existing shareholders if the 15,000 stock options are exercised.
• The value of the options is tied to the future market performance of BullFrog AI's common stock, introducing market risk for the option holder.
• The acceleration of vesting upon a 'significant financing' could lead to earlier dilution than initially planned.

Future Outlook

The stock options are designed to incentivize long-term performance, with vesting scheduled for September 2026 or the company's fiscal year 2026 annual meeting. The potential for accelerated vesting upon a change in control or significant financing suggests future strategic activities could impact the timing of option exercise.

Industry Context

The grant of stock options to a director is a common practice in the biotechnology and AI sectors, where companies often use equity compensation to attract and retain talent, aligning management incentives with long-term shareholder value creation. This is a standard mechanism for executive and director compensation in growth-oriented companies.

Comparison to Industry Standards

• Equity compensation plans, such as the 2022 Equity Compensation Plan, are standard across publicly traded companies, particularly in high-growth sectors like AI and biotech, to incentivize leadership.
• The exercise price being set at the market price on the grant date is a typical practice for incentive stock options, ensuring that the options gain value only if the company's stock price appreciates.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for future dilution if options are exercised, but also benefit from increased alignment of director's interests with company performance.
• Management/Director: Provides a long-term incentive and compensation component tied to the company's stock performance.

Next Steps

• The stock options will vest on the earlier of September 25, 2026, or the date of the company's annual meeting for fiscal year 2026.
• The options may be exercised by Jason David Hanson at any time after vesting and before the expiration date of September 25, 2035.

Key Dates

Recommendation

This Form 4 filing reports a routine grant of stock options to a director, which is a standard component of executive compensation. It does not provide new information that would fundamentally alter the company's financial outlook or operational performance, thus a 'hold' recommendation is appropriate as it doesn't warrant a change in investment thesis based solely on this filing.

Keywords

BullFrog AI, BFRG, Stock Options, Equity Compensation, Insider Transaction, Form 4, Jason Hanson, Director Compensation